+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genome Testing Market by Product Type (Instruments, Kits, Reagents & Consumables), Technology (Microarray, Next Generation Sequencing, PCR), Application, End User, Service Type - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Genome Testing Market by Product Type (Instruments, Kits, Reagents & Consumables), Technology (Microarray, Next Generation Sequencing, PCR), Application, End User, Service Type - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Genome Testing Market by Product Type (Instruments, Kits, Reagents & Consumables), Technology (Microarray, Next Generation Sequencing, PCR), Application, End User, Service Type - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 5925226
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genome testing market is rapidly evolving, driven by technology advances, shifting regulatory dynamics, and expanding clinical and consumer demand. Decision-makers face a complex and highly competitive landscape with rising opportunities for innovation, partnership, and differentiated growth.

Market Snapshot: Genome Testing Market Overview

The Genome Testing Market grew from USD 19.76 billion in 2024 to USD 22.45 billion in 2025. It is expected to continue growing at a CAGR of 13.36%, reaching USD 41.96 billion by 2030. This robust growth reflects accelerating adoption of next-generation sequencing, expansion into high-growth clinical applications, and a drive toward broader accessibility of genomics. Market innovation is enabled by decreasing sequencing costs, enhanced data analytics, and a competitive provider environment. Stakeholders must address evolving reimbursement requirements and regulatory shifts impacting both legacy and emerging solutions.

Scope & Segmentation: Genome Testing Coverage

  • Product Types: Instruments such as microarray scanners, PCR machines, and sequencers; kits including exome, targeted gene, and whole genome; reagents and consumables; and software and services offering analysis, data storage, and sequencing support.
  • Technologies: Microarray (expression arrays and SNP arrays), next generation sequencing platforms (Illumina, Ion Torrent), PCR methods (digital PCR, qPCR), and Sanger sequencing support key clinical and research workflows.
  • Applications: Include hereditary disease testing (carrier screening, rare disorder diagnostics), infectious disease detection (bacterial and viral), oncology diagnostics (liquid biopsy, solid tumor profiling), pharmacogenomics, and prenatal testing.
  • End Users: Research centers, universities, biotech companies, pharmaceutical firms, diagnostic labs (hospital and independent), direct-to-consumer providers, hospitals, and specialized clinics.
  • Service Types: Consumer testing (ancestry, fitness and nutrition-based wellness), clinical diagnostics (including companion diagnostics), and research services (clinical and preclinical support).
  • Regions: Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including U.K., Germany, France, and emerging MEA nations), and Asia-Pacific (China, India, Japan, Australia, and more).
  • Companies Analyzed: Profiles of market leaders such as Illumina, Thermo Fisher Scientific, Roche, QIAGEN, BGI Genomics, PerkinElmer, 23andMe, Myriad Genetics, Invitae, and Natera are included.

Key Takeaways for Senior Decision-Makers

  • Technological convergence is rapidly reshaping the competitive landscape, with adoption of next-generation sequencing and advanced bioinformatics enabling deeper genomic insight across applications.
  • Artificial intelligence and cloud-based analytics are streamlining laboratory operations and are making genomic analysis accessible to both large institutions and smaller research centers.
  • Clinical applications—ranging from oncology to infectious disease and hereditary testing—are expanding, supported by integration into personalized medicine and routine diagnostics.
  • Channel dynamics are shifting due to the rise of decentralized testing models, home-based sample collection, and direct-to-consumer services, which create new opportunities and challenges for providers.
  • Leading companies are investing in agile supply chains and regional manufacturing, aiming to enhance market resilience amid evolving policy and tariff environments.
  • Cross-industry collaboration and regulatory alignment are essential for navigating market complexity and capitalizing on global growth trends in genomics.

Tariff Impact: Navigating Policy Changes

The introduction of updated United States tariffs in 2025 is significantly influencing the genome testing supply chain. Increased duties on imported sequencing instruments, reagents, and consumables are adding cost pressures for laboratories and research providers. In response, companies are adjusting sourcing models, investing in domestic production, and reshaping distribution networks to maintain competitiveness. Collaboration in procurement and a focus on modular, regionally scalable product designs are emerging as viable strategies to counteract tariff-related challenges.

Methodology & Data Sources

This analysis draws on primary research, including interviews and structured discussions with industry executives and laboratory leaders. Secondary sources include scientific literature, press releases, company filings, and regulatory documents. Data triangulation and expert validation assure reliability and a comprehensive market perspective across product, technology, and regional segments.

Genome Testing Market: Why This Report Matters

  • Enables executives to benchmark competitive strategy and align R&D, sourcing, and regional expansion plans with opportunity areas in genomics.
  • Guides investment by identifying emerging technologies, application trends, and shifts in regulatory and reimbursement frameworks.
  • Equips decision-makers with actionable intelligence to navigate supply chain risks and tap into high-growth regional markets.

Conclusion

The genome testing market is defined by relentless innovation, evolving policy environments, and expanding clinical applications. Stakeholders equipped with granular industry insight can confidently shape strategies and capture value across this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genome Testing Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Microarray Scanners
8.2.2. PCR Machines
8.2.3. Sequencers
8.3. Kits
8.3.1. Exome Kits
8.3.2. Targeted Gene Kits
8.3.3. Whole Genome Kits
8.4. Reagents & Consumables
8.5. Software & Services
8.5.1. Analysis Services
8.5.2. Data Storage Software
8.5.3. Sequencing Services
9. Genome Testing Market, by Technology
9.1. Introduction
9.2. Microarray
9.2.1. Expression Arrays
9.2.2. SNP Arrays
9.3. Next Generation Sequencing
9.3.1. Illumina
9.3.2. Ion Torrent
9.4. PCR
9.4.1. Digital PCR
9.4.2. qPCR
9.5. Sanger Sequencing
10. Genome Testing Market, by Application
10.1. Introduction
10.2. Hereditary Disease Testing
10.2.1. Carrier Screening
10.2.2. Rare Disease
10.3. Infectious Disease Testing
10.3.1. Bacterial Detection
10.3.2. Viral Detection
10.4. Oncology Testing
10.4.1. Liquid Biopsy
10.4.2. Solid Tumor Profiling
10.5. Pharmacogenomics
10.6. Prenatal Testing
11. Genome Testing Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.2.1. Research Centers
11.2.2. Universities
11.3. Biotech & Pharma Companies
11.3.1. Biotech Companies
11.3.2. Pharma Companies
11.4. Diagnostic Laboratories
11.4.1. Hospital Labs
11.4.2. Independent Labs
11.5. Direct To Consumer
11.5.1. Online Providers
11.5.2. Retail Clinics
11.6. Hospitals & Clinics
11.6.1. Large Hospitals
11.6.2. Specialized Clinics
12. Genome Testing Market, by Service Type
12.1. Introduction
12.2. Consumer
12.2.1. Ancestry
12.2.2. Lifestyle & Wellness
12.2.2.1. Fitness
12.2.2.2. Nutrition
12.3. Diagnostic
12.3.1. Clinical Diagnostics
12.3.2. Companion Diagnostics
12.4. Research
12.4.1. Clinical Research
12.4.2. Preclinical Research
13. Americas Genome Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Genome Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Genome Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Illumina, Inc.
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. F. Hoffmann-La Roche AG
16.3.4. QIAGEN N.V.
16.3.5. BGI Genomics Co., Ltd.
16.3.6. PerkinElmer, Inc.
16.3.7. 23andMe, Inc.
16.3.8. Myriad Genetics, Inc.
16.3.9. Invitae Corporation
16.3.10. Natera, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENOME TESTING MARKET MULTI-CURRENCY
FIGURE 2. GENOME TESTING MARKET MULTI-LANGUAGE
FIGURE 3. GENOME TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENOME TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENOME TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENOME TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENOME TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GENOME TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GENOME TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENOME TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENOME TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENOME TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENOME TESTING MARKET SIZE, BY PCR MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENOME TESTING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENOME TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENOME TESTING MARKET SIZE, BY EXOME KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED GENE KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENOME TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENOME TESTING MARKET SIZE, BY ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENOME TESTING MARKET SIZE, BY DATA STORAGE SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENOME TESTING MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENOME TESTING MARKET SIZE, BY EXPRESSION ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENOME TESTING MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENOME TESTING MARKET SIZE, BY ILLUMINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENOME TESTING MARKET SIZE, BY ION TORRENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENOME TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENOME TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENOME TESTING MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENOME TESTING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENOME TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENOME TESTING MARKET SIZE, BY RARE DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENOME TESTING MARKET SIZE, BY BACTERIAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENOME TESTING MARKET SIZE, BY VIRAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENOME TESTING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENOME TESTING MARKET SIZE, BY SOLID TUMOR PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENOME TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENOME TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GENOME TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL GENOME TESTING MARKET SIZE, BY PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL GENOME TESTING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL GENOME TESTING MARKET SIZE, BY RETAIL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL GENOME TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL GENOME TESTING MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL GENOME TESTING MARKET SIZE, BY ANCESTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL GENOME TESTING MARKET SIZE, BY FITNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL GENOME TESTING MARKET SIZE, BY NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL GENOME TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL GENOME TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL GENOME TESTING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL GENOME TESTING MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 137. CANADA GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. CANADA GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 139. CANADA GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 140. CANADA GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 141. CANADA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. CANADA GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 143. CANADA GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 144. CANADA GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 145. CANADA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CANADA GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 147. CANADA GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 148. CANADA GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 149. CANADA GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. CANADA GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 151. CANADA GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 152. CANADA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 153. CANADA GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 154. CANADA GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 155. CANADA GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 156. CANADA GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 157. CANADA GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 158. CANADA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 159. CANADA GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 160. MEXICO GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 164. MEXICO GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. MEXICO GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 166. MEXICO GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 167. MEXICO GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 168. MEXICO GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. MEXICO GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 170. MEXICO GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 171. MEXICO GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 172. MEXICO GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. MEXICO GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 174. MEXICO GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 175. MEXICO GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 176. MEXICO GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 177. MEXICO GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. MEXICO GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 180. MEXICO GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 181. MEXICO GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 182. MEXICO GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 208. ARGENTINA GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 209. ARGENTINA GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 210. ARGENTINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. ARGENTINA GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 212. ARGENTINA GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 213. ARGENTINA GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 214. ARGENTINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ARGENTINA GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 216. ARGENTINA GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 217. ARGENTINA GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 218. ARGENTINA GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. ARGENTINA GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 220. ARGENTINA GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 221. ARGENTINA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 222. ARGENTINA GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 223. ARGENTINA GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 224. ARGENTINA GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 225. ARGENTINA GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 226. ARGENTINA GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 227. ARGENTINA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 228. ARGENTINA GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 256. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 260. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 264. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 268. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 276. GERMANY GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. GERMANY GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 278. GERMANY GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 279. GERMANY GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 280. GERMANY GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. GERMANY GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 282. GERMANY GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 283. GERMANY GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 284. GERMANY GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. GERMANY GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 286. GERMANY GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 287. GERMANY GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 288. GERMANY GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. GERMANY GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 290. GERMANY GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 291. GERMANY GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 292. GERMANY GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 293. GERMANY GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 294. GERMANY GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 295. GERMANY GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 296. GERMANY GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 297. GERMANY GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 298. GERMANY GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 299. FRANCE GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. FRANCE GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 301. FRANCE GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 302. FRANCE GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 303. FRANCE GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. FRANCE GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 305. FRANCE GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 306. FRANCE GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 307. FRANCE GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. FRANCE GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 309. FRANCE GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 310. FRANCE GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 311. FRANCE GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. FRANCE GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 313. FRANCE GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 314. FRANCE GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 315. FRANCE GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 316. FRANCE GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 317. FRANCE GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 318. FRANCE GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 319. FRANCE GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 320. FRANCE GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 321. FRANCE GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 322. RUSSIA GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. RUSSIA GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 324. RUSSIA GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 325. RUSSIA GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 326. RUSSIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 327. RUSSIA GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 328. RUSSIA GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 329. RUSSIA GENOME TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 330. RUSSIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. RUSSIA GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 332. RUSSIA GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 333. RUSSIA GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 334. RUSSIA GENOME TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. RUSSIA GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 336. RUSSIA GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 337. RUSSIA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 338. RUSSIA GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 339. RUSSIA GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 340. RUSSIA GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 341. RUSSIA GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2030 (USD MILLION)
TABLE 342. RUSSIA GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2030 (USD MILLION)
TABLE 343. RUSSIA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 344. RUSSIA GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 345. ITALY GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 346. ITALY GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 347. ITALY GENOME TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 348. ITALY GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Genome Testing market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • QIAGEN N.V.
  • BGI Genomics Co., Ltd.
  • PerkinElmer, Inc.
  • 23andMe, Inc.
  • Myriad Genetics, Inc.
  • Invitae Corporation
  • Natera, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 41.96 Billion
Compound Annual Growth Rate13.3%
Regions CoveredGlobal, United States
No. of Companies Mentioned11

Related Topics

Related Reports

Genome Engineering Market by Technology (CRISPR Systems, Meganucleases, Transcription Activator Like Effector Nucleases), Product (Instruments, Reagents & Consumables, Software & Services), Application, End User - Global Forecast 2025-2030 - Product Image

Genome Engineering Market by Technology (CRISPR Systems, Meganucleases, Transcription Activator Like Effector Nucleases), Product (Instruments, Reagents & Consumables, Software & Services), Application, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Product (Instruments), By Application (Diagnostics, Personalized Medicine), By Technology (Genome Sequencing, PCR), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Product (Instruments), By Application (Diagnostics, Personalized Medicine), By Technology (Genome Sequencing, PCR), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Whole Genome Amplification (WGA) - Global Strategic Business Report - Product Image

Whole Genome Amplification (WGA) - Global Strategic Business Report

  • Report
  • 396 Pages
  • Global
From
Mutation Detection Kits In Genome Editing Market by Technology (Cripsr, Meaganuclease, Talen), Detection Method (High Resolution Melt Analysis, Ngs, Pcr), Application, End User, Distribution Channel, Workflow Stage - Global Forecast 2025-2030 - Product Image

Mutation Detection Kits In Genome Editing Market by Technology (Cripsr, Meaganuclease, Talen), Detection Method (High Resolution Melt Analysis, Ngs, Pcr), Application, End User, Distribution Channel, Workflow Stage - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Whole Genome Sequencing - Global Strategic Business Report - Product Image

Whole Genome Sequencing - Global Strategic Business Report

  • Report
  • 464 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.